Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in VCYT — Veracyte, Inc.

CIK 1125816 Wheaton, IL
Back to VCYT Full portfolio

Position in VCYT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$147,289,084
+$79,099,033 QoQ
Shares Held
2,507,902
+18.5% QoQ
Ownership
3.12%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#8
of 367 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCYT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $1,364,038,790 across 24 Diagnostics & Research names. VCYT ranks #4 (10.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 2,079,578 $276,230,345
2 ILMN
Illumina, Inc.
 907,489 $159,563,790
3 NEO
Neogenomics Inc
 10,113,261 $147,552,477
4 VCYT
Veracyte, Inc.
This page 		2,507,902 $147,289,084
5 NTRA
Natera, Inc.
 511,214 $138,769,040
6 IDXX
Idexx Laboratories Inc /De
 202,754 $106,737,815
7 WAT
Waters Corp /De/
 272,470 $102,187,148
8 DGX
Quest Diagnostics Inc
 290,970 $61,671,091

All Filings in VCYT

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $147,289,084 2,507,902
2026-03-31 $68,190,051 2,117,046
2025-12-31 $54,035,476 1,283,503
2025-09-30 $45,486,048 1,324,965
2025-06-30 $28,974,321 1,071,932
2025-03-31 $30,939,804 1,043,501
2024-12-31 $8,080,063 204,042
2024-09-30 $2,715,268 79,767
2024-06-30 $403,538 18,622
2024-03-31 $1,802,760 81,352
2023-12-31 $2,437,496 88,604
2023-09-30 $2,291,861 102,636
2023-06-30 $3,492,420 137,119
2022-12-31 $1,581,343 66,639
2022-09-30 $479,590 28,891
2022-06-30 $250,939 12,610
2022-03-31 $964,591 34,987
2021-12-31 $1,426,673 34,628
2021-06-30 $1,312,383 32,826
2021-03-31 $3,379,047 62,866
2020-12-31 $2,097,274 42,854
2020-09-30 $569,744 17,536
2020-06-30 $1,528,514 59,016
2020-03-31 $1,499,829 61,696